BioNTech buys German mRNA vaccine peer CureVac in $1.2B deal
13 Jun 2025 //
FIERCE BIOTECH
Syntimmune Shareholders Win Again Over AZ, time for $181M
13 Jun 2025 //
FIERCE BIOTECH
Merck KGaA Sheds Light on Failed Portion of Phase 2 Lupus Trial
13 Jun 2025 //
BUSINESSWIRE
GSK Offloads Shigella Vaccine to Bharat Biotech Ahead of Phase 3
13 Jun 2025 //
PRESS RELEASE
Merck Initiates Phase 3 Study Evaluating Dengue Vaccine Candidate
13 Jun 2025 //
BUSINESSWIRE
Moderna Receives U.S. FDA Approval for RSV Vaccine
13 Jun 2025 //
REUTERS
Bavarian Nordic Initiates Ph 3 of Chikungunya Vaccine in Children
13 Jun 2025 //
GLOBENEWSWIRE
Amneal gets FDA approval for Prednisolone Acetate Ophthalmics
13 Jun 2025 //
GLOBENEWSWIRE
Novo Nordisk plans to Start Late-stage Trials of Obesity Drug
13 Jun 2025 //
GLOBENEWSWIRE
Drugs In Development

Market Intel
